Go to deals
Private Equity | TMT

IMendes has sold a majority stake to e-Auditoria

The private shareholder of IMendeson has sold a majority stake in the company to e-Auditoria.

IMendes is a leading tax software development company for tax and accounting automation in Brazil. It operates with a SaaS model, providing solutions to more than 30,000 clients across the entire national territory. The company offers tax engine solutions for automation of fiscal processes, reorganization of tax records, and XML validation of invoices with integration to the leading ERPs software in the market. Founded in 2008 by Izac Mendes, the company is headquartered in the city of Ribeirão Preto and has more than 55 employees, including dedicated software developers and tax specialists. IMendes’ solutions integrate with the best and most used ERP platforms in the market while leveraging the sales power of these partnerships to boost market penetration and to generate a profitable business model with recurring revenue. The company is experiencing strong growth in the past few years boosted by its cloud-based solutions and scalability. In addition, the complexity of the fiscal environment in Brazil demands this type of solution to ensure reliable fiscal procedure for businesses.

e-Auditoria is a technology company specializing in digital auditing. Its platform provides security and agility in detecting inconsistencies in accounting, tax and labor obligations, which reduces the risk of fines and audits from the tax authorities, in addition to identifying taxes collected incorrectly by companies, enabling the recovery of settlements. e-Auditoria was founded in 2009 by a group of entrepreneurs and Concept Investimentos, a Brazilian private equity firm, bought a majority stake in 2022.

One of Oaklins’ teams in Brazil acted as the exclusive financial advisor to IMendes and the shareholder in this transaction.

Parties
“At all times I was confident that the process was being conducted in a professional and transparent manner so that I could focus on the company and the high growth it is experiencing. Furthermore, Oaklins has a team of professionals who, in addition to being very competent, are tireless; they worked on the preparation process for future due diligence, they organized all the information, reconciling transparency with the truth. At many times I had the feeling that they were protecting my interests and those of IMendes as if they were my partners.”

Izac Mendes

Founder and CEO, IMendes

Talk to the deal team

Daniel Gildin

Partner
São Paulo, Brazil
Oaklins Fortezza Partners

Priscila Cardanha Rosas

Partner
São Paulo, Brazil
Oaklins Fortezza Partners

Related deals

Lumiforte partners with Kartesia to propel global growth and innovation
Private Equity | Agriculture | Other Industries

Lumiforte partners with Kartesia to propel global growth and innovation

Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.

Learn more
Yxion has been acquired by Normec
Private Equity | Business Support Services

Yxion has been acquired by Normec

Normec has acquired Dutch consultancy Yxion from Antea. Through this acquisition, Normec continues its acquisition strategy in Europe, while also looking for expansion opportunities in the United States.

Learn more
AMC Media Group has been acquired by Formedics
Healthcare | TMT

AMC Media Group has been acquired by Formedics

AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.

Learn more